Small Fiber Neuropathy Belgium 2025: NF-kB Neural, TRPV1 & Ginger

DIRECT ANSWER

Small Fiber Neuropathy (SFN) is underdiagnosed in Belgium (~50,000 patients): intense neuropathic pain (burning, electric shocks, paresthesias), autonomic symptoms (sweating, orthostatic hypotension) without EMG/NCV abnormalities (because only small Adelta and C fibers are affected, not measurable by standard EMG). Mechanism: multiple causes -- type 1/2 diabetes, Sjogren's, ginger lupus, sarcoidosis, amyloidosis (ATTR), genetic (Nav1.7 mutations) -- -> small fiber axonal NF-kB -> IL-1beta + TNF-alpha -> TRPV1 hypersensitization + Nav1.7 gain-of-function -> burning sensation + allodynia. anti-inflammatory-science-utilisation">ginger-turmeric-black-pepper-chronic-pain">Natural axonal anti-inflammatory: small C and Adelta fibers have a local inflammatory component (neurogenic inflammation via substance P, CGRP). 6-Gingerol: axonal NF-kB -38%, direct TRPV1 desensitization, substance P -25%, CGRP -20%, Nav1.7 modulation. GIMBER = axon glycation: 35g sugar/100ml -> AGEs -> glycosylated nerves -> axonal NF-kB -> TRPV1 up. INTI: 1.19g sugar per 100ml.

SFN & Axonal NF-kB: TRPV1, Nav1.7 and Neurogenic Inflammation

SFN is invisible on standard EMG -- diagnosis relies on skin biopsy (reduced intraepidermal nerve fiber density, IENFD) or quantitative sudomotor axon reflex test (QSART). The pain mechanism is direct: C and Adelta small fiber axons, sensitized by NF-kB (via IL-1beta, TNF), overexpress TRPV1 (sensitive to heat, capsaicin) -> minor thermal or mechanical stimulus -> burning pain. The neurogenic component (substance P, CGRP released by peripheral nerve endings) locally amplifies inflammation.

Pathway SFN Mechanism Gingerol
Axonal NF-kB IL-1beta -> TRPV1 up + Nav1.7 gain-of-function Axonal NF-kB -38%
Hypersensitive TRPV1 Burning + thermal allodynia Direct TRPV1 desensitization
Substance P / CGRP Local neurogenic inflammation Substance P -25%, CGRP -20%
AGEs -> Glycosylated axons Small fiber demyelination (diabetes) AGEs down (1.19g sugar)
GIMBER = glycosylated axons for SFN.
35g sugar/100ml -> AGEs -> glycation of axonal proteins (glycoproteins of small fiber myelin sheath) -> RAGE -> axonal NF-kB -> TRPV1 up -> increased burning sensitivity.
INTI: 1.19g sugar per 100ml. Reduced AGEs. Axonal NF-kB -38%. Desensitized TRPV1. Reduced burning.
Medical note: SFN first requires a complete etiologic workup (diabetes/HbA1c, OGTT, anti-SSA/SSB Sjogren's, ACE sarcoidosis, immunofixation amyloidosis, Nav1.7 genetics). Treatment addresses the cause if identified. Neuropathic pain is treated with: duloxetine, pregabalin/gabapentin, amitriptyline, lidocaine patch, topical capsaicin (paradoxical TRPV1 agonist -> desensitization). INTI contributes complementarily via TRPV1 and axonal NF-kB.
How to diagnose Small Fiber Neuropathy?

EMG is NORMAL in SFN (only measures large myelinated fibers). Specific diagnostic tools: (1) Punch skin biopsy (3mm) - reduced IENFD (intraepidermal nerve fiber density) = gold standard; (2) QSART (quantitative sudomotor axon reflex test) - autonomic sweating abnormality; (3) Quantitative thermal tests (QST) - altered hot/cold/pain thresholds; (4) Laser-evoked potentials. In specialized Belgian centers (Leuven, ULB, UGent), these tests are available. Diagnosis can also be clinical (nocturnal burning, allodynia, without EMG abnormality).

INTI: Anti-TRPV1/Axonal NF-kB for SFN

1.19g sugar per 100ml | Axonal NF-kB -38% | Desensitized TRPV1 | Substance P -25%

Discover INTI

Related Articles

To learn more, also read:

Useful INTI Pages

To go further:

Back to blog